TipRanks
Genor Biopharma Holdings Limited (DE:67N0)
FRANKFURT:67N0
Germany Market
67N0
Genor Biopharma Holdings Limited
RESEARCH TOOLSreports

Genor Biopharma Holdings Limited (67N0) Income Statement

0 Followers

Genor Biopharma Holdings Limited Income Statement

Last quarter (Q2 2026), Genor Biopharma Holdings Limited's total revenue was ¥873.70M, an increase of 5472.04% from the same quarter last year. In Q2, Genor Biopharma Holdings Limited's net income was ¥-65.91M. See Genor Biopharma Holdings Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 2.70B¥ 2.76B¥ 0.00¥ 18.53M¥ 0.00
Gross Profit
¥ 1.76B¥ 1.78B¥ -84.96M¥ -45.04M¥ -73.21M
Operating Expenses
¥ 1.07B¥ 1.07B¥ 686.81M¥ 869.22M¥ 1.03B
Depreciation and Amortization
¥ 264.83M¥ 210.53M¥ 84.96M¥ 62.42M¥ 73.21M
EBITDA
¥ 954.29M¥ 924.14M¥ -686.81M¥ -851.84M¥ -1.03B
Operating Income
¥ 689.46M¥ 713.61M¥ -771.77M¥ -914.26M¥ -1.11B
Other Income/Expenses
¥ -151.25M¥ -190.50M¥ 23.14M¥ 62.55M¥ 63.11M
Pretax Income
¥ 538.21M¥ 523.12M¥ -748.63M¥ -851.72M¥ -1.04B
Net Income
¥ 433.01M¥ 420.56M¥ -745.17M¥ -849.15M¥ -1.04B
Per Share Metrics
Basic EPS
¥ 0.23¥ -0.10¥ -1.33¥ -1.45¥ -1.75
Diluted EPS
¥ 0.22¥ -0.10¥ -1.33¥ -1.45¥ -1.74
Weighted Average Shares Outstanding
 1.67B 513.55M 506.25M 504.30M 495.18M
Weighted Average Shares Outstanding (Diluted)
 1.70B 513.55M 506.25M 504.81M 496.20M
Currency in CNY

Genor Biopharma Holdings Limited Earnings and Revenue History